LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1590
- Registration Number
- NCT06632457
- Locations
- 🇺🇸
Scottsdale Clinical Trials, Scottsdale, Arizona, United States
🇺🇸Synergy Healthcare, Brandon, Florida, United States
🇺🇸Optimus U Corporation-Miami-69452, Miami, Florida, United States
A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 80
- Registration Number
- NCT06631430
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in Men With Opioid Use Disorder Who Are Taking Buprenorphine
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 60
- Registration Number
- NCT06628622
- Locations
- 🇺🇸
Collaborative Neuroscience Research, LLC, Los Alamitos, Los Alamitos, California, United States
🇺🇸University of California Los Angeles, Los Angeles, California, United States
🇺🇸iResearch Atlanta, Decatur, Georgia, United States
A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT06631417
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
- Conditions
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 90
- Registration Number
- NCT06624670
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇨🇦University of Alberta Hospital (University of Alberta), Edmonton, Alberta, Canada
🇨🇦Centre de Recherche Saint-Louis, Quebec, Canada
A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food
- Conditions
- Interventions
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT06624072
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 50
- Registration Number
- NCT06619509
- Locations
- 🇪🇸
Fundación Jiménez Díaz, Madrid, Spain
🇪🇸Hospital Clínico San Carlos, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 200
- Registration Number
- NCT06581432
- Locations
- 🇫🇷
CTR Georges-François Leclerc, Dijon, France
🇫🇷HOP la Milétrie, Poitiers, France
🇫🇷INS Gustave Roussy, Villejuif, France
A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 106
- Registration Number
- NCT06575400
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body
- Conditions
- Interventions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 8
- Registration Number
- NCT06572111
- Locations
- 🇳🇱
ICON-Groningen-62040, Groningen, Netherlands